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doi:10.1016/j.jtcvs.2004.02.036Background: The early growth response 1 gene (Egr1) encodes for an immediate to
early response transcription factor that is upregulated by changes in vascular strain
and hypoxia and in turn upregulates the downstream expressions of a number of
angiogenic growth factors. We therefore hypothesized that early growth response 1
may be a critical early messenger governing revascularization in the setting of acute
vascular occlusions.
Methods: C57 BL/6 mice deficient in the Egr1 gene (knockout) and their wild-type
litter mates underwent ligation and excision of the femoral artery with or without the
previous administration of 2.7  109 particle units of an adenoviral vector coding
for the vascular endothelial growth factor gene (VEGF) or Egr1. Distal hind limb
perfusion was serially measured in these animals with laser Doppler perfusion
imaging.
Results: Wild-type mice (n  9) had nearly complete restitution of hind limb
perfusion by day 35 after ligation. In contrast, all noninjected Egr1 knockout mice
(n  5) had severe ipsilateral limb necrosis develop between 1 and 4 days after
ligation (P  .0001). Egr1 knockout mice injected with VEGF vector (n  4)
demonstrated significantly improved perfusion relative to baseline by postligation
day 28, which persisted to postligation day 35 (P  .05). Egr1 knockout animals
injected with Egr1 vector (n  7) demonstrated a partial recovery of hind limb
perfusion relative to VEGF vector–treated knockout animals at postligation day 4 (P
 .01), which persisted to day 35.
Conclusions: These findings suggest that early growth response 1 plays a pivotal
role in reperfusion responses to vascular occlusion in mice and possibly other
mammals.
The demonstrated ability of ischemia and hypoxia to upregulate theexpression of a number of angiogenic growth factors and theirreceptors has led to the assumption that ischemic upregulation ofthese growth factors underlies the development of collateral vesselsin the setting of vascular occlusion.1-4 Moreover, the apparent role ofthese growth factors in the endogenous processes of angiogenesis
and collateral vessel formation has led to the development of a strategy of thera-
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CSPpeutic angiogenesis, in which exogenous growth factors are
administered to ischemic tissues to enhance the reperfusion
of these tissues.5-8
Although a mechanism of ischemic upregulation of
growth factor expression as a stimulus for collateral vessel
formation intuitively follows from the known biology of
these proteins, several lines of evidence contradict this
premise. First, it has reasonably been noted that the tissues
surrounding a point of vascular occlusion are unlikely to be
ischemic, because tissues proximal to the vascular occlusion
will be perfused by the patent upstream vasculature and
tissues immediately distal to the occlusion point will likely
receive blood flow through existing vascular branches orig-
inating upstream from the ligation point.9,10 Second, the
therapeutic administration of individual growth factors has
shown that these proteins acting alone primarily stimulate
angiogenesis (capillary development) rather than arterio-
genesis (the development of larger collateral ves-
sels).7,8,11-15
The early growth response (EGR) 1 transcription factor
represents an intriguing alternative candidate transponder
capable of sensing the biophysical stimuli associated with
vascular occlusion and translating these stimuli into the
activation of appropriate effector molecules capable of in-
ducing angiogenesis and arteriogenesis.16-19 More specifi-
cally, the activity of EGR-1 is modulated by changes in
vascular wall shear stress such as would occur in the setting
of an acute vascular occlusion.20 EGR-1 in turn has been
shown to directly or indirectly upregulate the expression of
numerous vascular growth factors, including vascular endo-
thelial growth factor (VEGF), that are capable of inducing
or supporting angiogenesis and that may in concert be
capable of inducing collateral vessel formation.16-21
On the basis of these considerations, we hypothesized
that vascular occlusion could result in EGR-1 upregulation,
which in turn could induce revascularization through the
expression of downstream growth factors. We tested this
hypothesis by examining distal reperfusion after femoral
artery ligation in wild-type and Egr1 knockout animals.
Methods
Egr1 Knockout Animals
A colony of Egr1 / (knockout) C57 BL/6 mice (gift of Dr
Jeffrey Milbrandt, Washington University, St Louis, Mo)22,23 was
established at the Coon Research Center at Evanston Northwestern
Healthcare through standard breeding procedures. Animal han-
dling at all times was in accordance with institutional animal care
and use committee guidelines. All animals received humane care
in compliance with the “Guide for the Care and Use of Laboratory
Animals” (http://www.nap.edu/catalog/5140.html). Animals se-
lected from this colony underwent genotyping at 25 days after
birth, after which knockout and wild-type animals underwent
experimental studies at approximately 2 to 4 months of age.
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The adenovirus Egr1transfer vector (AdEgr) used for these studies
was also a gift of J. Milbrandt. The replication-defective VEGF
transfer vector (AdVEGF) used in these studies was an E1a,
partial E1b, partial E3 adenovirus vector based on human
adenovirus serotype 5 prepared as previously described else-
where.24-26 As a negative control, a similar adenovirus containing
no gene in the expression cassette (AdNull) was used. Vector
competency was assessed on HT1080 cells (ATCC No. CCl-121;
American Type Culture Collection, Manassas, Va), which were
treated with 50 particle units (pu)/cell of AdVEGF, AdEgr, or
AdNull, or with saline solution. Culture media was collected 48
hours later and subjected to enzyme-linked immunosorbent assay
(VEGF analysis),26 or cells were harvested into Trizol reagent
(Invitrogen, Carlsbad, Calif), and RNA was purified, reverse tran-
scribed, and subjected to semiquantitative polymerase chain reac-
tion (PCR) with rat Egr1 primers (GenBank Accession No. NM-
012551).27
Analysis of Egr1 Expression After Vascular Occlusion
In initial studies, male Sprague-Dawley rats (250-350 g; Harlan
Sprague Dawley, Inc, Indianapolis, Ind) treated in accordance with
institutional animal care and use committee guidelines were anes-
thetized with ketamine (80 mg/kg) and xylazine (12 mg/kg) ad-
ministered intraperitoneally. A midline abdominal incision was
then made, and the left common femoral artery was identified and
ligated. The left iliac and femoral arteries upstream from the
vascular ligation point were harvested 30, 60, or 120 minutes later,
and the right iliac and femoral arteries were taken as control
specimens for Northern blot analysis. The harvested vascular tis-
sues were homogenized in 1.0 mL Trizol reagent (Invitrogen), and
the total RNA was isolated according to the manufacturer’s in-
structions. RNA was then dissolved in water and quantified, and 10
g of total RNA was loaded on a 1% formaldehyde agarose gel.
After electrophoresis, RNA was transferred overnight by capillary
force to a Zeta-probe GT Genomic Tested Blotting Membrane
(Bio-Rad Laboratories Inc, Hercules, Calif) in 10 standard saline
citrate solution. The blot was ultraviolet cross-linked for 2 minutes
and then prehybridized with Hybrisol TM I (Oncor, Inc, Gaithers-
burg, Md) for 30 minutes before addition of phosphorus 32 ran-
domly primed labeling probe for mouse Egr1 (GenBank Accession
No. NM-007913). The membrane was hybridized overnight,
washed twice at room temperature for 20 minutes with 2 stan-
dard saline citrate solution plus 0.2% sodium dodecylsulfate and
then twice for 20 minutes with 0.2 standard saline citrate solu-
tion plus 0.2% sodium dodecylsulfate at 55°C. The blot was then
autoradiographed by exposure to x-ray film (X-Omat AR; Eastman
Kodak Company, Rochester, NY), and the autoradiograph signal
intensities were quantified with ImageQuant (Amersham Pharma-
cia Biotech, Inc, Piscataway, NJ).
Genotyping
All subsequent studies were performed in animals selected from
the C57 BL/6 knockout mouse colony described previously. Geno-
typing of these animals was performed from tail tip tissues ob-
tained after briefly placing the animals in an isoflurane chamber, as
28previously described elsewhere.
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PVascular Ligation
Wild-type or homozygous Egr1-deleted (knockout) animals
(25-35 g) selected from the C57 BL/6 mouse colony were anes-
thetized with pentobarbital (60 mg/kg intraperitoneally) after in-
duction with a mixture of isoflurane (3.5 L/min) and 100% oxygen
(3 L/min). A midline abdominal incision was then made, and the
proximal end of the femoral artery at the inguinal ligament and the
distal portion of the saphenous artery were ligated with 4-0 silk.
The artery and all side branches were then dissected free, and this
entire vascular segment was removed.29 The incision was then
closed, and the animal was allowed to recover according to stan-
dard protocols.
Laser Doppler Perfusion Study
Laser Doppler perfusion imaging was used to measure distal hind
limb perfusion before the operation and at serial time points after
vascular excision. Duplicate laser Doppler perfusion images were
obtained in a blinded manner with an LDPI system (Perimed,
Jarfalla, Sweden) through clipped and depilated hind limb skin
surfaces after placing the mice on a 37°C. heating pad for 10
minutes. Regions of interest (ROIs) encompassing either the entire
ligated limb or the contralateral nonligated hind limb were ana-
lyzed with accessory software provided by the manufacturer, as
previously described elsewhere.29 More specifically, the ROIs
were determined from black and white images (without perfusion
data) of the ventral surface of the animals by placing a standard,
computer-generated circle around the most distal aspect of each
hind limb, after which the system software was used to calculate a
mean intensity of Doppler signal within the ROI encompassed by
the circle. To minimize data variables caused by ambient light and
temperature, a perfusion index for each animal was expressed as
the average of the ratios of the ROIs for the ligated limb versus the
contralateral, nonligated limb.
Adenoviral Vector Injection
In initial studies assessing in vivo activity of the AdEgr vector,
male Sprague-Dawley rats were prepared as described previously,
and three 5-L injections of AdVEGF, AdEgr1, or AdNull (4 
109 pu/injection, total dose 1.2  1010 pu) or an equal volume of
phosphate-buffered saline solution were made through a midline
laparotomy into the proximal hind limb musculature. The animals
were allowed to recover, and the proximal hind limb musculature
was then harvested 48 hours later and subjected to semiquantita-
tive PCR analysis as previously described elsewhere.27
Administration of AdVEGF or AdEgr vectors was performed
24 hours before vascular ligation in subsets of wild-type and Egr1
knockout animals. These mice were anesthetized as described
previously, and an incision in the abdominal midline was made,
allowing exposure of the femoral artery, after which three 5
L-injections of AdVEGF or AdEgr1 (9  108 pu/injection, total
dose 2.7  109 pu) were made into the proximal hind limb
musculature. Animals were allowed to recover for 24 hours, after
which an ipsilateral double femoral artery ligation and excision
was performed as described previously.
Statistical Analysis
Data are expressed as mean  SD. Either 2 analysis or Student t
test was used to show significance, as appropriate.
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Egr1 Expression
Northern blot analysis of the iliofemoral vasculature har-
vested after femoral artery ligation performed in rats dem-
onstrated an approximate 2-fold increase of Egr1 messenger
RNA expression, which reached a maximum 60 minutes
after vascular ligation (Figure 1). Egr1 expression was
rapidly downregulated in these studies, returning to baseline
levels within 120 minutes after ligation. Egr1 signal upregu-
lation was specific to the ipsilateral vascular tissues proxi-
mal to the vascular ligation point. Neither the distal ipsilat-
eral nor the contralateral vasculature demonstrated a change
from baseline in the level of Egr1 expression (data not
shown).
Limb Ischemia in Egr1 Knockout Mice
All noninjected Egr1 knockout mice (n  5) and their
wild-type littermates (n  9) had severe hind limb ischemia
develop immediately after vascular ligation (Table 1), as
demonstrated by perfusion indices of 0.1  0.04 and 0.2 
0.05, respectively (P  .14), immediately after ligation
(Figure 2). The wild-type mice demonstrated a rapid recov-
ery of hind limb perfusion, generating an average perfusion
index of 0.5  0.1 at day 4 after ligation (P  .05 vs
baseline), which increased to an index of 0.8  0.2 by day
35 after ligation (P  .01 compared to baseline). In contrast
to the absence of observed morphologic or motor abnormal-
ities by day 35 in wild-type mice, all noninjected Egr1
knockout mice had severe necrosis of the ligated limb
Figure 1. Northern blot analysis of EGR-1 after iliac artery liga-
tion in rats. Left femoral artery was ligated, and proximal iliac
and femoral arteries were harvested as indicated. Right iliac and
femoral arteries were taken as control. Peak Egr1 expression is
noted 60 minutes after ligation. Lanes: 1, nonligated control; 2, 30
minutes after ligation (1.6  control); 3, 60 minutes after ligation
(2.1  control); 4, 120 minutes after ligation (0.6  control). EtBr,
Ethidium bromide.develop between 1 and 4 days after the procedure (Figure
c and Cardiovascular Surgery ● Volume 128, Number 4 597
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CSP3); this necrosis was so severe as to preclude further mea-
surements beyond these time points (P  .0001 vs necrosis
in wild-type animals; Table 1).
AdVEGF and AdEgr Rescue
The competencies of the AdVEGF and AdEgr vectors were
first validated in vitro by enzyme-linked immunosorbent
assay and semiquantitative PCR analyses, respectively (data
not shown). Administration of AdEgr into the hind limb
musculature of normal rats was then shown by semiquan-
titative PCR to induce an approximate 3- to 4-fold increase
in Egr1 expression relative to reduced glyceraldehyde-phos-
phate dehydrogenase standards, whereas AdVEGF admin-
istration demonstrated an intermediate increase and AdNull
or saline solution administration induced no appreciable
expression of Egr1 expression 48 hours after administration
(data not shown).
Egr1 knockout mice injected with AdVEGF before liga-
Table 1. Limb necrosis in ligated wild-type and Egr1
knockout mice
Group
Limb necrosis
Yes No
Wild-type (n  9) 0 9
Egr1 knockout (n  5) 5* 0
Wild-type plus AdVEGF (n  5) 0 5
Egr1 knockout plus AdVEGF (n  4) 0 4
Egr1 knockout plus AdEgr1 (n  7) 0 7
*P  .0001 versus wild type (2 test).
Figure 2. Distal hind limb perfusion after ipsilateral vascular
excision in wild-type and Egr1 knockout C57 BL/6 mice. Perfusion
index is calculated as described in Methods section from laser
Doppler perfusion imaging of ligated and nonligated hind limbs.tion (n  4) demonstrated an absence of necrosis (P 
598 The Journal of Thoracic and Cardiovascular Surgery ● Octo.0027 vs necrosis in untreated knockouts) and significantly
improved perfusion index by postligation day 28 compared
with the perfusion index immediately after ligation (P 
.05). This improvement persisted to postligation day 35 (0.7
 0.2, P  .01) and approximated that observed in ligated
wild-type animals (Figure 4). Egr1 knockout animals in-
jected with AdEgr (n  7) similarly demonstrated an ab-
sence of necrosis (P  .0005 vs necrosis in untreated
knockouts) and improvement of hind limb perfusion; im-
provement was less than that observed in AdVEGF-injected
knockouts through postligation day 4 (0.2  0.04, P  .01)
but then demonstrated a similar pattern of improvement
relative to AdVEGF-treated knockouts through day 35 after
ligation (Figure 5). Neither AdVEGF- nor AdEgr-treated
knockout animals demonstrated morphologic or motor ab-
normalities by day 35 after ligation (P  .003 vs untreated
knockouts).
Discussion
EGR-1 (also known as zif 268, TIS 8, nerve growth factor
induced A, and Krox 24) is an 80- to 82-kd, 533–amino acid
residue protein that is the prototypical member of the im-
mediate to early gene family of zinc-finger transcription
factors that includes EGR-2, EGR-3, and EGR-4. A grow-
ing body of data suggests that EGR-1 plays an important
role in a number of vascular homeostatic mechanisms.16-21
Data in this study suggest the potential importance of
EGR-1 in the normal reperfusion response to acute vascular
occlusion. These findings include (1) the demonstration of
rapid, transient upregulation of Egr1 messenger RNA ex-
pression in arterial tissues in response to acute vascular
occlusion (ligation) and (2) the near-total absence of reper-
fusion after vascular ligation in Egr1 knockout animals, as
quantified by laser Doppler analysis and confirmed by the
finding of extensive tissue necrosis in the ligated limbs.
Additional data demonstrating the “rescue” of the reperfu-
sion defect in Egr1 knockout animals by the administration
of AdEgr in these studies is presented as a positive control
for the Egr1 defect in knockout animals, whereas the dem-
onstration of reperfusion in Egr1 knockouts treated with
AdVEGF is consistent with an apparent downstream locus
for VEGF in the EGR-1 signaling pathway.
The studies described in this report follow our previous
observation of markedly upregulated expression of Egr1 in
a pneumonectomy and contralateral lung growth model.30
The apparent importance of Egr1 expression in this model
suggested to us that EGR-1 was critically responsive to
changes in shear stress after vascular ligation, analogous to
the hemodynamic changes expected with naturally occur-
ring atherosclerotic vascular occlusions. These observations
led us to suspect that EGR-1 might represent the previously
“missing” signaling factor capable of translating the phys-
iologic sequelae of vascular occlusion into the homeostatic
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Presponse of collateral vessel formation that follows this
biologic perturbation.
EGR-1 processing mechanisms are elegantly designed to
translate physiologic factors as stress and hypoxia into
modulation of gene expression and biologic responses.16-23
The responsiveness of Egr1 to biophysical stimuli occurs
through a series of serum response elements in the Egr
promoter region, to which a variety of intracellular proteins,
such as serum response factor and ternary complex factor,
can reversibly bind. These proteins are typically modified
and activated by cytoplasmic kinases, which in turn are
modulated by cytoplasmic and cell membrane stimuli, such
as cell stretching (shear stress). The serum response ele-
Figure 3. Laser Doppler perfusion images and macros
wild-type and Egr1 knockout mice. Perfusion is illustra
and blue-black being lowest. Perfusion images corr
intervals after ligation.ments promote the production of EGR-1, which then binds
The Journal of Thoracito the promoter region and enhances the expression of such
genes as those for platelet-derived growth factor A and B,
transforming growth factor , tissue factor, urokinase-type
plasminogen activator, and a number of the metalloprotein-
ases responsible for angiogenesis and vascular formation.
Importantly, Egr1 is inducibly expressed in many differ-
ent cell types relevant to the vascular signaling mechanism
presently under consideration, including endothelial cells,
smooth muscle cells, fibroblasts, and leukocytes. Aside
from shear stress and hypoxia, EGR-1 is also upregulated by
thrombin, acidic fibroblast growth factor, basic fibroblast
growth factor, epidermal growth factor, and VEGF. The
ability of EGR-1 to upregulate and be upregulated by a
appearances of ligated and nonligated hind limbs of
y means of color scale, with red-yellow being highest
with development of severe necrosis at indicatedcopic
ted b
elatenumber of proteins that act through autocrine and paracrine
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CSPmechanisms creates powerful amplification loops that ap-
pear to be ideally configured for a critical neovasculariza-
tion response to vascular occlusion.
Taken with the previous demonstration that shear stress
can upregulate Egr1 expression,18-20 and consistent with the
observations that proximal tissues in the setting of vascular
9,10
Figure 4. Distal hind limb perfusion after ipsilateral vascular
excision in Egr1 knockout mice treated with AdVEGF. For com-
parison purposes, shaded curve shows pattern of recovery in
wild-type mice, as shown in Figure 2.
Figure 5. Distal hind limb perfusion after ipsilateral vascular
excision in Egr1 knockout mice treated with AdEgr. For compar-
ison purposes, filled circles show pattern of recovery in AdVEGF-
treated knockouts, as shown in Figure 4. Difference in perfusion
from AdVEGF-treated Egr1 knockout animals on postligation day
35 was not significant.occlusion are not ischemic, the demonstration in the
600 The Journal of Thoracic and Cardiovascular Surgery ● Octopresent study that Egr1 expression is upregulated in pre-
sumably nonischemic vascular tissues upstream from a vas-
cular ligation site supports our hypothesis that factors other
than ischemia may play a role in reperfusion after vascular
occlusion. Additional studies would, however, need to be
performed to fully test this hypothesis, specifically includ-
ing the demonstration of upregulation of EGR-1 protein, as
opposed to messenger RNA expression, and the demonstra-
tion of upregulated Egr1 expression in nonischemic cells in
this model.
These studies also suggest that EGR-1 plays a critical
role in the normal revascularization response to acute vas-
cular occlusion that may take precedence over other, appar-
ently nonredundant, signaling pathways implicated in the
ischemia and revascularization response mechanisms, such
as the hypoxia-inducible factor pathway. Previous evidence
that EGR-1 can upregulate VEGF expression, for example,
is consistent with this finding.16-20 Conversely, although a
greater number of animals would need to be examined to
resolve any potential differences between the therapeutic
effects of VEGF relative to EGR-1, the limb salvage pro-
vided by VEGF in the current studies also reaffirms the
ability of VEGF, and presumably other downstream growth
factors, to induce physiologically meaningful vasculariza-
tion, in this case, even in the absence of an intact Egr1
pathway.
In light of evidence that EGR-1, like other transcription
factors, can activate the expressions of a number of vascular
development genes, it is possible that EGR-1 can induce
vasculogenesis and collateral vessel formation to an extent
that exceeds the angiogenesis generated by administration
of single growth factors such as VEGF. Although these
considerations are appealing conceptually, additional stud-
ies will need to be performed to confirm the role of EGR-1
in native arteriogenesis and to determine whether the use of
EGR-1 and related factors might yield important new and
more robust vasculogenic therapeutics than the use of single
growth factors, such as VEGF, for the treatment of athero-
sclerosis and vascular occlusive disease.
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